EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Integrative and Emerging Models in Antibody Research: A Comprehensive Review

Jagadeeswara Reddy Devasani iD, Girijasankar Guntuku, Prathyusha Sarabu, Murali Krishna Kumar Muthyala, Mary Sulakshana Palla, Mallikarjuna Subrahmanyam Volety

Antibody Therapeutics · 16.10.2025 · 8 (4) · 317-335

DOI: 10.1093/abt/tbaf018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibody Therapeutics, online erschienen am 28.08.2025. Verfasst von Jagadeeswara Reddy Devasani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Biotechnology Division, A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh 530003, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody research has advanced through the integration of in vivo, in vitro, and in silico models, each offering distinct advantages and limitations. In vivo models, such as traditional animal models and humanized mouse models, provide critical insights into antibody efficacy and pharmacokinetics but face ethical and translational challenges. In vitro techniques, including hybridoma technology, phage display, and B-cell culture, enable efficient screening and optimization but often lack physiological relevance. In silico approaches, powered by computational biology and machine learning, accelerate antibody design and prediction, addressing challenges in cost and scalability. Emerging technologies like CRISPR-based engineering, single-cell sequencing, microfluidics, and organ-on-chip platforms are reshaping antibody discovery and therapeutic development. This review critically evaluates these models, emphasizing their integration to overcome existing challenges such as reproducibility, immunogenicity prediction, and scalability. As innovations continue, a multidisciplinary approach promises to enhance antibody research, driving next-generation therapeutics for cancer, autoimmune diseases, and infectious conditions.

Schlagwörter

Stichwörter der Autor:innen

CRISPR-based engineeringantibody discoveryantibody researchexperimental modelsorgans-on-chips

Autor:innen und Institutionen

  • Pharmaceutical Biotechnology Division, A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh 530003, India.
  • Pharmaceutical Chemistry Division, A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh 530003, India.
  • GITAM School of Pharmacy, GITAM Deemed to be University, Rishikonda, Visakhapatnam, Andhra Pradesh 530045, India.
  • Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (Deemed University), Manipal, Karnataka 576104, India.

ORCID-Profile: Jagadeeswara Reddy Devasani

Zitieren

APA

Devasani, J. R., Guntuku, G., Sarabu, P., Muthyala, M. K. K., Palla, M. S., & Subrahmanyam Volety, M. (2025). Integrative and Emerging Models in Antibody Research: A Comprehensive Review. Antibody Therapeutics, 8(4), 317-335. https://doi.org/10.1093/abt/tbaf018

Vancouver

Devasani JR, Guntuku G, Sarabu P, Muthyala MKK, Palla MS, Subrahmanyam Volety M. Integrative and Emerging Models in Antibody Research: A Comprehensive Review. Antibody Therapeutics. 2025;8(4):317-335. doi:10.1093/abt/tbaf018

BibTeX
@article{Devasani2025,
  author = {Devasani, Jagadeeswara Reddy and Guntuku, Girijasankar and Sarabu, Prathyusha and Muthyala, Murali Krishna Kumar and Palla, Mary Sulakshana and Subrahmanyam Volety, Mallikarjuna},
  title = {Integrative and Emerging Models in Antibody Research: A Comprehensive Review},
  journal = {Antibody Therapeutics},
  year = {2025},
  volume = {8},
  number = {4},
  pages = {317--335},
  doi = {10.1093/abt/tbaf018}
}
Kostenlos starten →